Gilde Healthcare neemt Sanquin Reagents over
Investeert in schaalvergroting en ontwikkeling nieuwe medische tests
Gilde Healthcare portfolio company Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study
Implantable shock absorber demonstrates clinically meaningful pain relief and functional improvement in data presented at OSET
23 september 2022
Gilde Healthcare portfolio company Amphista Therapeutics named as a “Fierce 15” biotech company of 2022
test
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced that Fierce Biotech has named it as one of 2022’s Fierce 15 biotechnology companies, designating it as one of the most promising early-stage biotechnology companies in the industry. Amphista is a world leading next-generation Targeted Protein Degradation (TPD) company with the […]
Gilde Healthcare Company Volta Medical publishes clinical results on AI based solution for patients in atrial fibrillation
test
Volta Medical, a pioneering health tech company developing artificial intelligence (AI) software solutions to assist electrophysiologists to treat cardiac arrhythmias, announced that the Journal of Cardiovascular Electrophysiology (JCE) has published peer-reviewed results from the Company’s successful Ev-AIFib Study. The Proof-of-Concept-Study investigated the use of Volta’s lead product VX1, an expertise-based AI software solution to assist […]
Gilde Healthcare company Moximed raises $40 Million to advance world’s first Implantable Shock Absorber for Knee Osteoarthritis
Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced $40 million in Series C equity and debt financing. The round was led by Advent Life Sciences. In addition to Gilde Healthcare the round also...
Gilde Healthcare company Nalu appoints Thomas West as new president and CEO
Nalu Medical, Inc. (“Nalu”), a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced that the Board of Directors has appointed Thomas “Tom” West as President and Chief Executive Officer. This leadership appointment is effective on August 8th and follows the decision...
Gilde Healthcare bolsters its Private Equity team in Frankfurt office
Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV. With the recruitment of Martin von Berg as Investment Manager and Lara Hilgert as Investment...
Gilde Healthcare company Zetacom acquires communication specialist Ooperon
Dutch communication system integrator Zetacom B.V. announced the acquisition of communication specialist Ooperon B.V.
Gilde Healthcare invests in German precision surgical instruments contract manufacturer Chr. Diener
Leading contract manufacturer of highly complex, customer-specific, surgical instruments partners with Gilde Healthcare to further build on the company’s 122-year heritage.
Loading...
These were all messages
02f3cc09bb